Views: 30 Author: Unibest Industrial Publish Time: 2024-04-11 Origin: Site
Query Drug:Belzutifan
Query Time:2024-04-11 13:18:28
*** Disclaimer *** The information provided here is sourced from resources such as Drugs.com, the Orange Book, etc., and is auto-generated by the Unibest Digital Center. The content is intended exclusively for pharmaceutical professionals. Unibest does NOT accept legal responsibility for ANY medical actions taken based on this information. ALWAYS consult with your doctor for medical advice.
Belzutifan is used in people with von Hippel-Lindau disease (VHL), a rare genetic condition that can cause tumors to develop in certain organs of the body.
Belzutifan is for use in adults with VHL who need treatment for certain tumors of the kidneys, pancreas, or brain and spinal cord. Belzutifan is used when these tumors do not require surgery right away.
von Hippel-Lindau Disease
Source MEDRT
Source FDASPL
Source DAILYMED
Source MEDRT
Source FDASPL
Source DAILYMED
Source FDASPL
Source DAILYMED
[Last update] 2024-03-08
Belzutifan's Innovator is MERCK SHARP AND DOHME CORP A SUB OF MERCK AND CO INC
The unique dosage forms from the innovator include:1. TABLET;ORAL.
Index | Route | Brand Name | Labeler | Approval Date | Dosage |
---|---|---|---|---|---|
1 | TABLET;ORAL | WELIREG | MERCK SHARP AND DOHME CORP A SUB OF MERCK AND CO INC | Aug 13, 2021 | 40MG |
This drug still has 2 effective patents.
Patent Number | Submission Date | Expiration Date | Drug Substance Patent? | Drug Product Patent? |
---|---|---|---|---|
9908845 | Sep 9, 2021 | Sep 5, 2034 | Y | Y |
9969689 | Sep 9, 2021 | Sep 5, 2034 | Y | Y |
The innovator MERCK SHARP AND DOHME CORP A SUB OF MERCK AND CO INC's portolio contains products with the following 6 API(s): DORAVIRINE; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE,APREPITANT,BELZUTIFAN,DORAVIRINE,POSACONAZOLE,CILASTATIN SODIUM; IMIPENEM; RELEBACTAM